Clinical benefit with intraoperative radiotherapy combined with regional chemotherapy for advanced pancreatic carcinoma
Objective: To evaluate the effectiveness of intraoperative radiotherapy (IORT) in combination with regional chemotherapy in the treatment of advanced pancreatic carcinoma.Methods: 17 patients with advanced pancreatic adenocarcinoma were treated with IORT and regional chemotherapy with 5-FU, Epirubucin and Mitomycin, and 6 cases accepted external radiotherapy postoperatively.Results: 35.29% (6/17) of the patients were clinical benefit responders and 23.53% (4/17) had a partial response. The median survival time was 11 months and the 1-year survival rate was 35.29% (6/17)Conclusion: IORT in combination with regional chemotherapy had a good impact on clinical benefit without severe side effects in locally advanced pancreatic carcinoma and led to a significant prolongation of the survival time.
Key wordspancreatic cancer intraoperative radiotherapy chemotherapy
Unable to display preview. Download preview PDF.
- 4.Burris H. Objective outcome measures of quality of life. Oncology (Huntingt), 1996, 10: 131–135.Google Scholar
- 7.Li JG, Jin HK, Touboul E. Simultaneous chemoradiotherapy for locally advanced pancreatic cancer. Chin J Radiat Oncol, 2001, 10: 232–235.Google Scholar
- 9.Peng LH, Xu J, Liu TF,et al. The clinical effect of intraoperative radiotherapy and gemcitabine for locally advanced pancreatic cancer. Chin J Cancer Prev Treat, 2002, 9: 323–324.Google Scholar